Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer

John R. Goffin; Ian C. Anderson; Jeffrey G. Supko; Joseph Paul Eder; Geoffrey I. Shapiro; Thomas J. Lynch; Margaret Shipp; Bruce E. Johnson; Arthur T. Skarin

doi:10.1158/1078-0432.ccr-04-2144

Phase I Trial of the Matrix Metalloproteinase Inhibitor Marimastat Combined with Carboplatin and Paclitaxel in Patients with Advanced Non–Small Cell Lung Cancer

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-04-2144 ◽

2005 ◽

Vol 11 (9) ◽

pp. 3417-3424 ◽

Cited By ~ 26

Author(s):

John R. Goffin ◽

Ian C. Anderson ◽

Jeffrey G. Supko ◽

Joseph Paul Eder ◽

Geoffrey I. Shapiro ◽

...

Keyword(s):

Lung Cancer ◽

Matrix Metalloproteinase ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Matrix Metalloproteinase Inhibitor ◽

Small Cell Lung ◽

The Matrix

Download Full-text

Toxicity and Response of Pemetrexed Plus Carboplatin or Cisplatin with Concurrent Chest Radiation Therapy (CRT) for Patients with Locally Advanced Non–small-cell Lung Cancer (LANSCLC): A Phase I Trial

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2009.07.266 ◽

2009 ◽

Vol 75 (3) ◽

pp. S110 ◽

Cited By ~ 1

Author(s):

J.H. Heinzerling ◽

R.S. Hughes ◽

R. Govindan ◽

J.D. Bradley ◽

J.D. Schiller ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Locally Advanced ◽

Small Cell ◽

Small Cell Lung

Download Full-text

The effect of bexarotene on atorvastatin pharmacokinetics: results from a phase I trial of bexarotene plus chemotherapy in patients with advanced non-small cell lung cancer

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-011-1772-z ◽

2011 ◽

Vol 69 (2) ◽

pp. 563-571 ◽

Cited By ~ 10

Author(s):

Heather A. Wakelee ◽

Chris H. Takimoto ◽

Arturo Lopez-Anaya ◽

Quincy Chu ◽

Gary Middleton ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text

p53 gene therapy for non-small cell lung cancer: a preliminary report of phase I trial

The Japanese Journal of Pharmacology ◽

10.1016/s0021-5198(19)47621-x ◽

2000 ◽

Vol 82 ◽

pp. 36

Author(s):

Toshivoshi Fujiwara ◽

Masafumi Kataoka ◽

Atsushi Nakamura ◽

Noriaki Tanaka

Keyword(s):

Lung Cancer ◽

Gene Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Preliminary Report ◽

Phase I Trial ◽

P53 Gene ◽

Small Cell ◽

Small Cell Lung

Download Full-text

P-575 Preclinical and preliminary phase I trial results of motexafin gadolinium (MGd) with docetaxel & cisplatin in non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/s0169-5002(05)81068-2 ◽

2005 ◽

Vol 49 ◽

pp. S269-S270

Author(s):

D. Stewart ◽

Y. Oh ◽

R. Schaerer ◽

L. Naumobski ◽

S. Phan

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung ◽

Motexafin Gadolinium ◽

Preliminary Phase

Download Full-text

High-dose tamoxifen in combination with cisplatin in non-small cell lung cancer (NSCLC): Phase I trial and pharmacokinetic analysis

Lung Cancer ◽

10.1016/0169-5002(94)94216-1 ◽

1994 ◽

Vol 11 ◽

pp. 116

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Pharmacokinetic Analysis ◽

High Dose ◽

Small Cell Lung

Download Full-text

P-578 A phase I trial of gemcitabine, carboplatin or gemcitabine paclitaxel and concurrent radiation therapy followed by consolidative gemcitabine and carboplatin for inoperable stage III non-small cell lung cancer: An RTOG study

Lung Cancer ◽

10.1016/s0169-5002(05)81071-2 ◽

2005 ◽

Vol 49 ◽

pp. S270

Author(s):

S. Swann ◽

H. Choy ◽

C. Walter ◽

G. Whipple ◽

W. Demas ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Small Cell Lung

Download Full-text

A phase I trial of gefitinib and nimotuzumab in patients with advanced non-small cell lung cancer (NSCLC)

Lung Cancer ◽

10.1016/j.lungcan.2012.11.017 ◽

2013 ◽

Vol 79 (3) ◽

pp. 270-275 ◽

Cited By ~ 11

Author(s):

Se Hyun Kim ◽

Hyo Sup Shim ◽

Jaeho Cho ◽

Jae Heon Jeong ◽

Sun Mi Kim ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text

Vinorelbine/gemcitabine in advanced non-small-cell lung cancer (NSCLC): A phase I trial

European Journal of Cancer ◽

10.1016/s0959-8049(97)86049-2 ◽

1997 ◽

Vol 33 ◽

pp. S252

Author(s):

R. Pirker ◽

G. Krajnik ◽

A. Mohn-Staudner ◽

F. Marhold ◽

R. Malayeri ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text

A Phase I Trial of Outpatient Weekly Irinotecan/Carboplatin and Concurrent Radiation for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbilt-Ingram Cancer Center Affiliate Network Trial

Clinical Lung Cancer ◽

10.3816/clc.2000.n.014 ◽

2000 ◽

Vol 1 (4) ◽

pp. 310-311 ◽

Cited By ~ 6

Author(s):

A. Chakravarthy ◽

Hak Choy

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Stage Iii ◽

Cancer Center ◽

Small Cell Lung

Download Full-text

Phase I trial of oral CP-547,632 (VEGFR2) in combination with paclitaxel (P) and carboplatin (C) in advanced non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3014 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3014-3014 ◽

Cited By ~ 7

Author(s):

R. B. Cohen ◽

G. Simon ◽

C. J. Langer ◽

J. R. Schol ◽

J. McHale ◽

...

Keyword(s):

Lung Cancer ◽

Phase I ◽

Small Cell Lung Cancer ◽

Cell Lung Cancer ◽

Phase I Trial ◽

Small Cell ◽

Small Cell Lung

Download Full-text